The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from note payable, related parties | 0 | 0 |
| Proceeds from sale of common stock | 0 | 0 |
| Net cash flows from financing activities | 0 | 0 |
| Amortization of debt discounts | 0 | 0 |
| Gain on extinguishment of debt | 0 | 0 |
| Gain on forgiveness of accrued compensation | 0 | 0 |
| Loss on change in fair value of derivative liability | 0 | 0 |
| Non- cash amortization of prepaid contracts | 193,242 | 380,182 |
| Stock-based compensation | 1,071,333 | 883,942 |
| Shares issued for services | - | 66,000 |
| Prepaid and other current assets | -32,324 | 60,132 |
| Operating lease right of use asset | 639 | 1,908 |
| Increase in other liabilities | 6,695 | - |
| Accounts payable and accrued expenses | -95,612 | 177,481 |
| Accrued compensation | -8,867 | 442,826 |
| Increase in accrued interest | 1,108 | 2,178 |
| Net loss | -2,288,034 | -3,781,832 |
| Net cash flows from operating activities | -1,154,450 | -1,891,263 |
| Net change in cash | -1,154,450 | -1,891,263 |
| Cash and cash equivalents at beginning of period | 3,769,510 | - |
| Cash and cash equivalents at end of period | 723,797 | - |
JUPITER NEUROSCIENCES, INC. (JUNS)
JUPITER NEUROSCIENCES, INC. (JUNS)